Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F E Durr

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Chinese Medical Journal|March 1, 1987
Activation of natural killer cells with 3,6-bis (2-piperidinoethoxy) acridine trihydrochloride (CL 246, 738)B S Wang, A L Lumanglas, J S Veronica, et al.
Cancer Treatment Reports|September 1, 1987
Effect of hyperthermia on the sensitivity of human colon carcinoma cells to mitoxantroneB S Wang, A L Lumanglas, J Silva, et al.
International Journal of Immunopharmacology|January 1, 1986
Inhibition of the induction of alloreactivity with mitoxantroneB S Wang, A L Lumanglas, J Silva, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1986
The mechanism of action of 3,6-bis(2-piperidinoethoxy)acridine trihydrochloride (CL 246,738) in the potentiation of natural killer cellsB S Wang, A L Lumanglas, J Silva, et al.
Cellular Immunology|October 15, 1989
Internalization and shedding of Lym-1 monoclonal antibody following interaction with surface antigens of a cultured human B cell lymphomaB S Wang, K A Kelley, A L Lumanglas, et al.
Cancer Research|April 15, 1988
Restoration of cytolytic T-lymphocyte response with a new immunopotentiator, N-(4-[(4-fluorophenyl)sulfonyl]phenyl)acetamide (CL 259, 763), in miceB S Wang, V M Ruszala-Mallon, A L Lumanglas, et al.
Journal of Medicinal Chemistry|July 23, 1993
N-phosphoryl derivatives of bisantrene. Antitumor prodrugs with enhanced solubility and reduced potential for toxicityK C Murdock, V J Lee, R V Citarella, et al.
International Journal of Immunopharmacology|January 1, 1984
Induction of alloreactive immunosuppression by 1,4-bis [( 2-aminoethyl)amino]-5,8-dihydroxy-9,10-anthracenedione dihydrochloride (CL 232,468)B S Wang, A L Lumanglas, V M Ruszala-Mallon, et al.
Cancer Research|July 15, 1993
Preparation and characterization of monoclonal antibody conjugates of the calicheamicins: a novel and potent family of antitumor antibioticsL M Hinman, P R Hamann, R Wallace, et al.
Cancer Research|February 1, 1982
Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in miceR V Citarella, R E Wallace, K C Murdock, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Chinese Medical Journal|March 1, 1987
Activation of natural killer cells with 3,6-bis (2-piperidinoethoxy) acridine trihydrochloride (CL 246, 738)B S Wang, A L Lumanglas, J S Veronica, et al.
Cancer Treatment Reports|September 1, 1987
Effect of hyperthermia on the sensitivity of human colon carcinoma cells to mitoxantroneB S Wang, A L Lumanglas, J Silva, et al.
International Journal of Immunopharmacology|January 1, 1986
Inhibition of the induction of alloreactivity with mitoxantroneB S Wang, A L Lumanglas, J Silva, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1986
The mechanism of action of 3,6-bis(2-piperidinoethoxy)acridine trihydrochloride (CL 246,738) in the potentiation of natural killer cellsB S Wang, A L Lumanglas, J Silva, et al.
Cellular Immunology|October 15, 1989
Internalization and shedding of Lym-1 monoclonal antibody following interaction with surface antigens of a cultured human B cell lymphomaB S Wang, K A Kelley, A L Lumanglas, et al.
Cancer Research|April 15, 1988
Restoration of cytolytic T-lymphocyte response with a new immunopotentiator, N-(4-[(4-fluorophenyl)sulfonyl]phenyl)acetamide (CL 259, 763), in miceB S Wang, V M Ruszala-Mallon, A L Lumanglas, et al.
Journal of Medicinal Chemistry|July 23, 1993
N-phosphoryl derivatives of bisantrene. Antitumor prodrugs with enhanced solubility and reduced potential for toxicityK C Murdock, V J Lee, R V Citarella, et al.
International Journal of Immunopharmacology|January 1, 1984
Induction of alloreactive immunosuppression by 1,4-bis [( 2-aminoethyl)amino]-5,8-dihydroxy-9,10-anthracenedione dihydrochloride (CL 232,468)B S Wang, A L Lumanglas, V M Ruszala-Mallon, et al.
Cancer Research|July 15, 1993
Preparation and characterization of monoclonal antibody conjugates of the calicheamicins: a novel and potent family of antitumor antibioticsL M Hinman, P R Hamann, R Wallace, et al.
Cancer Research|February 1, 1982
Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in miceR V Citarella, R E Wallace, K C Murdock, et al.
Pageof 4